Automated Blood Processing Equipment Market Outlook:
Automated Blood Processing Equipment Market size was valued at USD 2.23 billion in 2025 and is expected to reach USD 4.68 billion by 2035, expanding at around 7.7% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of automated blood processing equipment is evaluated at USD 2.38 billion.

The increasing number of road traffic accidents across the world will exponentially help the automated blood processing equipment market to grow in the expected CAGR. Approximately 2 million people lose their lives in automobile accidents yearly. Additionally, there are 30 to 60 million non-fatal injury issues, many of which outcome in lifetime disability. Road traffic accidents are foreseeable and avoidable, but reliable statistics are necessary to comprehend how road safety technologies and treatments may be successfully implemented in industrialized nations where they are successful.
Another reason to propel automated blood processing equipment market by the end of 2036 is the continuous need for diagnostic tests for different diseases globally. Expands the panel of tests for infectious and vaccine-preventable diseases and non-communicable diseases (including diabetes and cancer). It also includes the WHO-recommended COVID-19 tests (PCR and Antigen) and adds a section on endocrinology—a crucial area for women's and reproductive health. The list now contains tests that should not be provided in countries for the first time, either because they are too expensive, too unreliable, or have been superseded by more user-friendly, more recent technologies. The public and policymakers are unaware of the effects of traffic injuries. In developing nations, comprehensive measures for road safety must be incorporated into national planning. In many low- and middle-income countries, basic diagnostic capacity is only accessible in 1% of primary-care clinics due to a systemic lack of testing investment.
Key Automated Blood Processing Equipment Market Insights Summary:
Regional Highlights:
- The North America automated blood processing equipment market will dominate around 35% share by 2035, driven by increasing technological advancements in blood processing.
- The Europe market will hold the second largest share by 2035, fueled by the rising number of blood donors in the region.
Segment Insights:
- The automatic blood processing system segment in the automated blood processing equipment market is projected to achieve substantial growth through 2035, driven by increasing adoption and regulatory approvals for automation in blood centers.
- The blood banks segment in the automated blood processing equipment market is expected to achieve a 34% share by 2035, driven by the increasing number of blood banks globally and high donation rates.
Key Growth Trends:
- Lack of Knowledge in People
- Increase in Pollution
Major Challenges:
- Higher Rate of Costs of Automated Blood Collection Devices
- Lack of Knowledge in People
Key Players: Nipro Medical Corporation, Business PlanningMain Product OfferingsFinancial ExecutionMain Performance IndicatorsBD, Terumo BCT Inc., Fresenius KABI AG, Grifols S.A., Greiner AG, Quest Diagnostics Incorporated, Macopharma, SARSTEDT AG & Co. KG, ICU Medical, Inc.
Global Automated Blood Processing Equipment Market Forecast and Regional Outlook:
Market Size & Growth Projections:
- 2025 Market Size: USD 2.23 billion
- 2026 Market Size: USD 2.38 billion
- Projected Market Size: USD 4.68 billion by 2035
- Growth Forecasts: 7.7% CAGR (2026-2035)
Key Regional Dynamics:
- Largest Region: North America (35% Share by 2035)
- Fastest Growing Region: Asia Pacific
- Dominating Countries: United States, Germany, Japan, China, United Kingdom
- Emerging Countries: China, India, Japan, South Korea, Thailand
Last updated on : 16 September, 2025
Automated Blood Processing Equipment Market Growth Drivers and Challenges:
Growth Drivers
- Increase in Chronic Diseases Globally - The majority of the global disease burden is accounted for by the rise in the burden of chronic illness over time. While the epidemiology of chronic disease burden differs by nation, most industrialized and developing nations have significant chronic disease burden rates. The same procedures primary care physicians use to test for depression or diabetes should also be used to screen for sleep issues. Access to reasonably priced, successful treatments for sleep problems, such as cognitive behavioral therapy, should be made possible by governments and healthcare systems. This is particularly crucial for blacks, American Indians, Alaska Natives, and others with lower incomes. Studies reveal that racial or ethnic minorities experience more sleep disturbances and specific sleep disorders than other racial or ethnic groups, yet they also receive fewer diagnoses and less treatment.
- Increasing Campaign for Blood Donation Programs - All of Lifeblood's donors are urged to become social media celebrities. Their website provides a four-step strategy to help donors spread the word about the need for 33,000 contributions each week to help meet the need for products made from blood and plasma. The New York Blood Center is aware of the critical role that community influencers play in bringing awareness to the ongoing need for blood. To guarantee the success of their influencers, they have developed an online resource that offers social media postings, photos, videos, brochures, and more. Physicians worldwide utilize blood supplies to treat a wide range of illnesses, including cancer, anemia, heart, kidney, and stomach disorders, traumatic injuries sustained in emergencies, natural disasters, and accidents, among others.
- Increasing Prevalence of Patients Experiencing Chemotherapy - It is predicted that there will be 26 million new cases of cancer in 2040, the majority of which will occur in low- and middle-income nations. In 2018, there were about 17 million new cases of cancer. The study projects that by 2040, two-thirds (67%) of patients in need of chemotherapy will reside in these nations, as will 75% of the 5.2 million more patients who would require the treatment by then.
Challenges
- Higher Rate of Costs of Automated Blood Collection Devices- Blood collection tubes are made of sterile plastic and have a colored rubber stopper that seals the tube to produce a vacuum that makes it simpler to remove a certain volume of liquid. Serum separator tubes are most frequently used for venipuncture blood sample collection. Additives intended to stabilize and preserve the specimen before analytical testing may be present in some tubes. Rubber stoppers, which are safety-engineered closures, come in a range of draw volumes, labeling options, and stopper colors for tubes.
- Blood cultures (BCs), still regarded as the gold standard for pathogen identification and susceptibility profile assessment, are used to detect pathogens, bacteria, or fungi responsible for BSI diagnosis. The proper collection and prompt delivery of BCs have a significant impact on the diagnostic yield. Additionally, safety during BC sampling must be addressed with the right protocols and by involving personnel who have received specific training.
- Lack of Knowledge in People
- Increase in Pollution
Automated Blood Processing Equipment Market Size and Forecast:
Report Attribute | Details |
---|---|
Base Year |
2025 |
Forecast Period |
2026-2035 |
CAGR |
7.7% |
Base Year Market Size (2025) |
USD 2.23 billion |
Forecast Year Market Size (2035) |
USD 4.68 billion |
Regional Scope |
|
Automated Blood Processing Equipment Market Segmentation:
System Segment Analysis
The automatic blood processing system segment will grow the most by the forecast period and will hold almost 67% in the automated blood processing equipment market because of the increasing use of automatic blood processing systems across the world. For instance, the United States Food and Drug Administration (US FDA) has now approved the Reveos Select Blood Bag Set and Automated Blood Processing System for use in commerce in the US. The blood center can experience significant operational improvements and benefits from automation. The Reveos system is an intuitive platform that unifies and automates the laborious tasks involved in processing whole blood, from the beginning to the end, including the extraction of platelets. Blood transfusions, which are acknowledged as essential bodily fluids, can significantly contribute to a patient's survival in life-threatening circumstances. However, to prevent the spread of infectious diseases such as HIV/AIDS, Hepatitis, and others, the blood obtained from the donor must be thoroughly examined before transfusion. For this reason, various equipment for collecting, processing, and analyzing blood samples is used. The blood samples are then divided into different blood components, such as plasma, platelets, WBCs, and RBCs, to treat patients who are deficient in a particular blood component or whole blood. Thus, this segment will hold the highest position in the automated blood processing equipment market.
End User Industries Segment Analysis
The blood banks segment will have superior growth during the forecast period and will hold around 34% of the revenue share of the automated blood processing equipment market owing to the increasing prevalence of blood banks globally. Approximately 13,300 blood centers spread across 169 nations claim to have collected 106 million donations in total. Blood centers have different collections depending on the income bracket. Compared to 25,700 in high-income countries, the median annual contributions per blood center are 1,300 in low-income countries, 4,400 in lower-middle-income countries, and 9,300 in upper-middle-income countries.
Our in-depth analysis of the global automated blood processing equipment market includes the following segments:
Product |
|
Type |
|
Device Type |
|
System |
|
Application |
|
End-User Industries |
|

Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Automated Blood Processing Equipment Market Regional Analysis:
North American Market Insights
The automated blood processing equipment market in the North America region will have the biggest growth during the forecast period with a revenue share of around 35%. This growth will be noticed owing to the increasing advancement in technology for blood processing in this region. Advanced biomedical technologies may soon be accessible, enabling people to achieve greater mental clarity physical health, and strength than ever before. These technologies have the potential to push the limits of human potential. However, a recent Pew Research Center survey of American adults reveals that the majority of respondents are less enthusiastic and hopeful about the prospect of these advances and are instead wary and worried.
European Market Insights
The automated blood processing equipment market in the Europe region will also encounter huge growth during the forecast period and will hold the second position owing to the rising number of blood donors in this region. Blood donation is essential to the EU's healthcare systems because it gives them the resources, they need to treat patients and give them hope for recovery. Through regulation, the European Union has made great strides toward encouraging voluntary and unpaid blood donation. It passed a Directive in 2002 that established the guidelines for blood donation procedures inside the EU.

Automated Blood Processing Equipment Market Players:
- Nipro Medical Corporation
- Company Overview
- Business Planning
- Main Product Offerings
- Financial Execution
- Main Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- BD
- Terumo BCT Inc.
- Fresenius KABI AG
- Grifols S.A.
- Greiner AG
- Quest Diagnostics Incorporated
- Macopharma
- SARSTEDT AG & Co. KG
- ICU Medical, Inc.
Recent Developments
- Nipro Medical Corporation, a foremost producer, and supplier of renal, vascular, and medical-surgical materials, hailed a second-generation Cronus HP PTA Balloon Catheter to the U.S.
- Nipro Medical Corporation, a foremost producer, and supplier of renal, vascular, and medical-surgical materials, declared the business launch of SURDIAL DX Hemodialysis System to the U.S. SURDIAL DX is an avant-garde hemodialysis system planned to develop an optimum dialysis therapy experience for patients and clinicians. Produced in Japan, it extracted from over 35 years of expertise in renal device creation at Nipro’s parent organization, Nipro Corporation.
- Report ID: 5922
- Published Date: Sep 16, 2025
- Report Format: PDF, PPT
- Get detailed insights on specific segments/region
- Inquire about report customization for your industry
- Learn about our special pricing for startups
- Request a demo of the report’s key findings
- Understand the report’s forecasting methodology
- Inquire about post-purchase support and updates
- Ask About Company-Level Intelligence Additions
Have specific data needs or budget constraints?
Frequently Asked Questions (FAQ)
Automated Blood Processing Equipment Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
See how top U.S. companies are managing market uncertainty — get your free sample with trends, challenges, macroeconomic factors, charts, forecasts, and more.
Copyright @ 2025 Research Nester. All Rights Reserved.
